CV DEATH HAS A NEW OPPONENT
CV DEATH HAS A NEW OPPONENT

Empagliflozin (JARDIANCE) improves the QoL of HF patients

Document ID: PC-PH-104044

06/12/2022

Author: Boehringer Ingelheim

Related content

 
PC-PH-104044
Production date: December 2022